Education
About Us
Working with TipRanks
Follow Us
Exozymes Inc. (EXOZ)
:EXOZ
EXOZ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.50 - $23.99
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.62K
Market Cap
N/A
Enterprise Value$129.74M
Total Cash (Recent Filing)$8.51M
Total Debt (Recent Filing)$1.33M
Price to Earnings (P/E)―
Beta1.33
Next Earnings
Apr 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,367,810
10 Day Avg. Volume7,648
30 Day Avg. Volume8,617
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-930.80
Enterprise Value/Ebitda-15.24
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
eXoZymes News
EXOZ FAQ
What was Exozymes Inc.’s price range in the past 12 months?
Exozymes Inc. lowest stock price was $8.50 and its highest was $23.99 in the past 12 months.
What is Exozymes Inc.’s market cap?
Currently, no data Available
When is Exozymes Inc.’s upcoming earnings report date?
Exozymes Inc.’s upcoming earnings report date is Apr 08, 2026 which is in 246 days.
How were Exozymes Inc.’s earnings last quarter?
Currently, no data Available
Is Exozymes Inc. overvalued?
According to Wall Street analysts Exozymes Inc.’s price is currently Overvalued.
Does Exozymes Inc. pay dividends?
Exozymes Inc. does not currently pay dividends.
What is Exozymes Inc.’s EPS estimate?
Exozymes Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exozymes Inc. have?
Exozymes Inc. has 8,367,810 shares outstanding.
What happened to Exozymes Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Exozymes Inc.?
Currently, no hedge funds are holding shares in EXOZ
Company Description
Exozymes Inc.
eXoZymes (EXOZ) is a biotechnology company focused on the development and commercialization of enzyme-based solutions for various industrial applications. Operating within the biotechnology and environmental sectors, eXoZymes leverages advanced enzyme engineering to create sustainable and efficient processes for industries such as agriculture, waste management, and biofuels. The company's core products are customized enzymes that enhance productivity and reduce environmental impact.
eXoZymes (EXOZ) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Protagenic Therapeutics
―
Ownership Overview
63.48% Insiders
0.80% Mutual Funds
― Other Institutional Investors
35.39% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---